Related Experiment Videos

[Antibodies as specific tumor therapy agents. Wishful thinking or reality?]

M Gramatzki¹, T Valerius

¹Abteilung für Hämatologie/Onkologie, Medizinische Klinik III mit Poliklinik, Universität Erlangen-Nürnberg.

|February 7, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Organ-on-a-chip models for development of cancer immunotherapies.

Cancer immunology, immunotherapy : CII·2023

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Journal of internal medicine·2019

CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.

Scandinavian journal of immunology·2017

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2017

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2016

See all related articles